GranuFlo & NaturaLyte

The U.S. Food and Drug Administration (FDA) have issued a recall of the GranuFlo and NaturaLyte, popular dialysis products from Fresenius Medical Care (FMC), the company responsible for manufacturing. The FDA has stated that this is a Class 1 recall, indicating the severity of the potential health risks, including death, associated with both of the hemodialysis drugs GranuFlo and NaturaLyte.

Patients who have used GranuFlo and NaturaLyte for dialysis treatment have noted the onset of several serious health consequences. The products have been associated with an increased risk of cardiopulmonary arrest and sudden cardiac death. The makers of the products, Fresenius Medical Care, neglected to warn patients and physicians of the potential dangers associated with the drugs until this past year. Unfortunately, there is evidence linking the FMC to documents which indicate the company knew of the health risks prior to warning patients and health care professionals.

More than half of all dialysis patients across the United States were given either one of these dangerous drugs, which makes them 6 times more likely to develop cardiopulmonary arrest and sudden cardiac death. The makers of the products are currently under watch as they have grossly misled patients about the hazards involved with both GranuFlo and NaturaLyte.

Due to the severity of risks linked to these dangerous drugs, if you have received treatments of the hemodialysis drugs GranuFlo or NaturaLyte, you must seek medical attention immediately. After securing your health, it is critical that you contact a class action attorney as soon as possible.

To hear more from a Connecticut lawyer, please complete a Free Case Review on this page.

GranuFlo and NaturaLyte Side Effects

The high bicarbonate levels linked to both GranuFlo and NaturaLyte have been connected to several very serious health risks. The company failed to release this information about the dangerous products, which serve to clean the blood of patients with damaged kidneys in dialysis machines. As more and more information trickles down, it is clear that FMC has dropped the ball in neglecting to inform both the FDA and health-care providers when they previously knew of the health risks linked to their products.

The following are some of the most common side effects currently documented from the use of GranuFlo and NaturaLyte:

  • Hypercapnia
  • Low blood pressure
  • Hypoxemia
  • Cardiac Arrhythmia
  • Heart attack
  • Stroke
  • Cardiopulmonary arrest
  • Sudden cardiac death
  • Cardiovascular death

The leading cause of death in dialysis patients is cardiac death. With over 5,700 dialysis centers and 400,000 dialysis patients across the United States, it is clear that massive number of people have been affected by the dangerous drugs released by FMC, the largest company in the U.S. for dialysis services and products.

If you or a loved one has suffered after the use of GranuFlo and/or NaturaLyte, you may be entitled to compensation for the injuries that you have had to deal with. Jonathan Perkins Injury Lawyers
believes that FMC must pay for the health risks that they have failed to inform the public about, thus causing about 900 deaths across the country.

To get started today, simply fill out a Free Case Review on this page.

Fresenius Medical Care (FMC) Fails to Release Vital Information

The FMC conducted an internal case-control study to evaluate risk factors from cardiopulmonary arrest patients in FMC facilities compared to non-FMC facilities. This study took place between January 1st and December 31st of 2010. The FDA did not issue a recall on GranuFlo or NaturaLyte until March 29, 2012. The delay was due to the massive blunder by FMC to keep this information internal.

Following the study, which found that 841 patients in 667 FMC facilities had died due to a cardiopulmonary arrest, a memo was released internally to doctors and dialysis facilities associated with FMC. However, no one outside of FMC, including the FDA, was informed of the serious health risks linked to both GranuFlo and NaturaLyte.

Jonathan Perkins Injury Lawyers believes that FMC must pay for the enormous error in neglecting to inform the FDA of such a serious medical matter. If you or a loved one has been affected by these dangerous drugs, contact our class action attorneys today.

Connecticut Class Action Attorneys

More than 30 percent of the 400,000 Americans who receive dialysis treatment were given GranuFlo or NaturaLyte. This indicates that over 120,000 patients are at serious risk of developing the many medical complications associated with these dialysis drugs. At Jonathan Perkins Injury Lawyers, we strongly believe that the manufacturers of defective drugs must be held liable for their negligence.

If you or a loved one has suffered any of the listed side effects after receiving treatment with either of the hemodialysis drugs, GranuFlo or NaturaLyte, you may be entitled to compensation. We are prepared to guide you throughout the entire litigation process, utilizing our years of experience and expert resources to achieve the compensation that you deserve!

Complete a Free Case Review at your earliest convenience to get started today.

Top